Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Fisher & Paykel Healthcare Corporation stock

FPH.NZ
NZFAPE0001S2
881319

Price

36.07 NZD
Today +/-
+0.04 NZD
Today %
+0.22 %
P

Fisher & Paykel Healthcare Corporation stock price

NZD
%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Fisher & Paykel Healthcare Corporation stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Fisher & Paykel Healthcare Corporation stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Fisher & Paykel Healthcare Corporation stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Fisher & Paykel Healthcare Corporation's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Fisher & Paykel Healthcare Corporation Stock Price History

DateFisher & Paykel Healthcare Corporation Price
11/1/202436.07 NZD
10/31/202435.99 NZD
10/30/202435.65 NZD
10/29/202436.06 NZD
10/25/202436.84 NZD
10/24/202437.10 NZD
10/23/202437.06 NZD
10/22/202437.20 NZD
10/21/202437.64 NZD
10/18/202437.01 NZD
10/17/202436.61 NZD
10/16/202436.50 NZD
10/15/202437.13 NZD
10/14/202436.79 NZD
10/11/202437.20 NZD
10/10/202436.60 NZD
10/9/202436.05 NZD
10/8/202435.35 NZD
10/7/202434.62 NZD

Fisher & Paykel Healthcare Corporation Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Fisher & Paykel Healthcare Corporation, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Fisher & Paykel Healthcare Corporation from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Fisher & Paykel Healthcare Corporation’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Fisher & Paykel Healthcare Corporation. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Fisher & Paykel Healthcare Corporation’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Fisher & Paykel Healthcare Corporation’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Fisher & Paykel Healthcare Corporation’s growth potential.

Fisher & Paykel Healthcare Corporation Revenue, EBIT and net profit per share

DateFisher & Paykel Healthcare Corporation RevenueFisher & Paykel Healthcare Corporation EBITFisher & Paykel Healthcare Corporation Net Income
2027e2.54 B NZD712.25 M NZD527.96 M NZD
2026e2.27 B NZD594.12 M NZD441.15 M NZD
2025e2.02 B NZD492.45 M NZD365.72 M NZD
20241.74 B NZD353.4 M NZD132.6 M NZD
20231.58 B NZD332.2 M NZD250.3 M NZD
20221.68 B NZD505.6 M NZD376.9 M NZD
20211.97 B NZD712.3 M NZD524.2 M NZD
20201.26 B NZD379.3 M NZD287.3 M NZD
20191.07 B NZD292.6 M NZD209.2 M NZD
2018980.8 M NZD269.8 M NZD190.2 M NZD
2017894.41 M NZD240.12 M NZD169.15 M NZD
2016815.49 M NZD211.08 M NZD143.43 M NZD
2015672.35 M NZD170.08 M NZD113.17 M NZD
2014623.4 M NZD143.5 M NZD97.1 M NZD
2013556.3 M NZD112.7 M NZD77.1 M NZD
2012516.7 M NZD92.8 M NZD64.1 M NZD
2011506.1 M NZD97.7 M NZD52.5 M NZD
2010503.3 M NZD99.6 M NZD71.6 M NZD
2009458.7 M NZD102.4 M NZD62.2 M NZD
2008357.9 M NZD58.1 M NZD35.3 M NZD
2007356.5 M NZD89.6 M NZD57.6 M NZD
2006324.5 M NZD104.1 M NZD70 M NZD
2005240.6 M NZD89.7 M NZD61.4 M NZD

Fisher & Paykel Healthcare Corporation Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B NZD)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B NZD)EBIT (M NZD)EBIT MARGIN (%)NET INCOME (M NZD)NET INCOME GROWTH (%)DIV. (NZD)DIV. GROWTH (%)SHARES (M)DOCUMENTS
199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
0.680.80.920.210.210.210.240.320.360.360.460.50.510.520.560.620.670.820.890.981.071.261.971.681.581.742.022.272.54
-17.4014.94-76.81-2.802.8812.1535.009.880.2828.299.830.601.987.7512.057.8721.289.699.629.1818.0456.06-14.71-5.9510.1815.7312.3512.14
--------58.1550.4253.7153.8854.7453.2955.2258.5961.0163.9366.0066.3366.8266.1163.1762.5859.3359.93---
000000000.210.180.250.270.280.280.310.370.410.520.590.650.720.841.251.050.941.04000
6192130817379891048958102999792112143170211240269292379712505332353492594712
8.9211.4614.0837.8535.1036.9237.0832.1025.0016.2522.2719.6819.1717.8320.1422.9525.3025.8926.8527.4527.2930.0136.1230.0421.0020.2624.4026.2328.03
18541148725461705735627152647797113143169190209287524376250132365441527
-200.00-79.63336.3650.00-25.0012.9614.75-18.57-38.6077.1414.52-26.7623.0820.3125.9716.4926.5518.1812.4310.0037.3282.58-28.24-33.51-47.20176.5220.8219.50
-----------------------------
-----------------------------
587.7588.2590.6560.9519.8524.1523.8524.8524.8524.9527.4529.8536.3536.3559.1557.8569.55572.04574.34574.34578.05579.05579.59579.99581.63586.18000
-----------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Fisher & Paykel Healthcare Corporation Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Fisher & Paykel Healthcare Corporation is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M NZD)RECEIVABLES (M NZD)OTHER REC. (M NZD)INVENTORIES (M NZD)OTHER CURRENT LIAB. (M NZD)CURRENT ASSETS (M NZD)TANGIBLE ASSETS (B NZD)LONG-T. INVEST. (k NZD)LONG-T. REC. (M NZD)INTANGIBLE ASSETS (M NZD)GOODWILL (M NZD)OTHER NON-CURRENT ASSETS (M NZD)NON-CURRENT ASSETS (B NZD)TOTAL ASSETS (B NZD)LIABILITIESCOMMON STOCK (M NZD)ADDITIONAL PAID-IN CAPITAL (M NZD)RETAINED EARNINGS (B NZD)OTHER EQUITY (M NZD)UNREAL. GAINS/LOSSES (M NZD)EQUITY (B NZD)LIABILITIES (M NZD)PROVISIONS (M NZD)OTHER SHORT-TERM LIAB. (M NZD)SHORT-TERM DEBTS (M NZD)LONG-TERM DEBT PORTION (M NZD)SHORT-TERM REC. (M NZD)LONG-T. LIAB. (M NZD)DEFERRED TAXES (M NZD)OTHER LIAB. (M NZD)LONG-T. LIABILITIES (M NZD)DEBT (M NZD)TOTAL CAPITAL (B NZD)
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                 
5.37.773.348.347.637.128.67.75.35.56.96.16.37.710.413.618.7461.25132.3140.7144.8377.6289.912182
110.6117.833.630.133.838.549.65356.575.462.770.668.172.984.795.7116.23115.42127.8136192.9191.7142.8179.6219.5
183176.48.3308.710.45.95.713.714.3119.59.510.11013.617.0116.2619.923.330.437.239.974.646.7
147162.119.221.924.130.936.246.750.869.971.880.184.489.194.596.1120.95134.98125.4136.1146.5270.6358.9365.8320.4
006.23.58.410.85.253.37.627.720.226.735.335.324.212.7921.1718.819.24.142.956.433.236.3
445.9464140.6133.8122.6127.7125.5118.1129.6172.7180.1186.5195215.1234.9243.2285.72349.08424.2455.3518.7920887.9774.2704.9
0.360.360.060.070.070.080.130.140.190.20.230.250.310.350.350.370.390.430.480.60.740.880.961.151.34
00000000000000000000001003000
114.4113.13.73.10.90.50.30.40.91.91.61.51.81.72.23.402.472.52.62.37.63.229.92.4
001.71.82.22.42.32.23.33.43.91.55.47.292135.7644.4850.461.573.98086.885.688.4
3.332.62.21.81.410.61113.911.51.51.5000000000
413.53.516.525.115.510.311.310.430.255.269.957.246.43333.350.715771.685.9104.8185.3171.3166.6146
0.480.490.070.10.10.10.140.160.20.240.30.330.380.40.40.430.480.530.60.750.921.161.221.431.58
0.930.950.220.230.220.230.270.270.330.410.480.520.570.620.630.670.760.881.031.211.442.082.112.22.28
                                                 
000000006.16.315.240.865.492.8121.9147.4165.64183.49201.4221229251.3266.3307409.1
0000000000000000000000000
000000000.190.190.20.190.190.20.230.270.330.40.480.560.711.051.21.221.12
385.9384171.9192.8191.2192204193.50.9-1.870.176.37459.434.321.612.0926.4430.244.3-53.2100.297.957.146.3
00000000010.910.910.924.124.124.132.5053.5353.587.687.6122.1122.1169.7187
0.390.380.170.190.190.190.20.190.20.210.30.320.350.370.410.470.510.660.760.920.981.521.681.761.76
50.947.78.48.710.815.119.215.914.723.722.821.122.521.123.227.736.9629.3232.755.169.356.753.84332.4
0000000011.916.91920.122.525.726.930.134.1239.3943.447.457.187.593.894.5108.6
61.2112.225.92313.314.219.323.418.829.931.525.825.427.132.945.262.1555.7872.464.6116256.7139.3131147.8
19.261.31.16.36.25.55.58.65.724.517.180.217.114.214.216.2915.6816.117.330.711.95.34.21.1
176.5188.76.2201.818.335.456.517.8000031.6005.4213.8061.514.711.717.195.1
307.8354.641.834.830.437.362.380.2110.59497.884.1150.691128.8117.2149.52145.58178.4184.4334.6427.5303.9289.8385
223.8183.21.501.900021.197.559.681.934.5117.463.651.346.8539.9552.5694491.887.3124.592.9
000000000015.227.224.323.12115.710.1715.3817.223.30003.15.6
8.431.60.21.20.70.91.114.518.19.31114.514.810.814.518.5915.6615.616.882.634.836.133.739.1
232.2214.81.71.22.60.91.1125.6115.684.1120.173.3155.395.481.575.6170.9985.3109.1126.6126.6123.4161.3137.6
540569.443.5363338.263.481.2136.1209.6181.9204.2223.9246.3224.2198.7225.13216.57263.7293.5461.2554.1427.3451.1522.6
0.930.950.220.230.220.230.270.270.330.420.480.520.570.620.630.670.740.881.031.211.442.082.112.212.29
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Fisher & Paykel Healthcare Corporation provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Fisher & Paykel Healthcare Corporation's financial health and stability.

Assets

Fisher & Paykel Healthcare Corporation's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Fisher & Paykel Healthcare Corporation must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Fisher & Paykel Healthcare Corporation after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Fisher & Paykel Healthcare Corporation's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M NZD)DEPRECIATION (M NZD)DEFERRED TAXES (M NZD)CHANGES IN WORKING CAPITAL (M NZD)NON-CASH ITEM (M NZD)PAID INTEREST (M NZD)PAID TAXES (M NZD)NET CASH FLOW FROM OPERATING ACTIVITIES (M NZD)CAPITAL EXPENDITURES (M NZD)CASH FLOW FROM INVESTING ACTIVITIES (M NZD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M NZD)INTEREST INCOME AND EXPENSES (M NZD)NET DEBT CHANGE (M NZD)NET CHANGE IN EQUITY (M NZD)CASH FLOW FROM FINANCING ACTIVITIES (M NZD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M NZD)TOTAL DIVIDENDS PAID (M NZD)NET CHANGE IN CASH FLOW (M NZD)FREE CASH FLOW (M NZD)SHARE-BASED COMPENSATION (M NZD)
1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
00000000000000000000000376250
000000000000000000000008693
00000000000000000000000-64
4040433332110013502400455684122
00000000000000000000000-107-41
-25-23-28-10000-2-5-9-6-6-4-4-7-5-5-6-2-4-5-4-4-9
-10-15-14-24-40-24-29-26-25-15-22-23-25-24-25-27-44-63-74-69-81-93-131-249-121
61871056746607296564462137719386104146144193247253321625324238
-60-65-48-13-16-8-16-52-27-13-22-48-43-67-62-31-53-65-62-98-133-170-184-169-211
-57-94-45280-518-13-51-16-13-22-48-43-67-62-31-53-65-62-198-125-155-387-89-11
3-293293-341630100000000000-99715-20280200
0000000000000000000000000
3852-290-50015194228-2972118-22-45-80210-14-10-14-4
000-1850-2-7-40-110723232627100000000
0-7-42-277-54-56-65-50-48-35-37-90-37-24-26-66-90-74-87-79-113-159-188-235-197
322-12320000000000000012333
-41-61-14-79-52-56-58-62-68-68-66-68-68-70-71-72-47-68-89-102-114-146-181-224-195
6172120131239593117745996130921001151451952313283346421809575397
1.122.356.654.629.551.855.34428.730.939.789.127.826.424.472.293.2578.81130.59149.1120150.7440.6154.526.9
0000000000000000000000000

Fisher & Paykel Healthcare Corporation stock margins

The Fisher & Paykel Healthcare Corporation margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Fisher & Paykel Healthcare Corporation. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Fisher & Paykel Healthcare Corporation.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Fisher & Paykel Healthcare Corporation's sales revenue. A higher gross margin percentage indicates that the Fisher & Paykel Healthcare Corporation retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Fisher & Paykel Healthcare Corporation's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Fisher & Paykel Healthcare Corporation's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Fisher & Paykel Healthcare Corporation's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Fisher & Paykel Healthcare Corporation. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Fisher & Paykel Healthcare Corporation's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Fisher & Paykel Healthcare Corporation Margin History

Fisher & Paykel Healthcare Corporation Gross marginFisher & Paykel Healthcare Corporation Profit marginFisher & Paykel Healthcare Corporation EBIT marginFisher & Paykel Healthcare Corporation Profit margin
2027e59.93 %28.04 %20.79 %
2026e59.93 %26.23 %19.48 %
2025e59.93 %24.43 %18.14 %
202459.93 %20.28 %7.61 %
202359.35 %21.01 %15.83 %
202262.6 %30.06 %22.41 %
202163.19 %36.14 %26.59 %
202066.14 %30.02 %22.73 %
201966.87 %27.34 %19.54 %
201866.31 %27.51 %19.39 %
201766.01 %26.85 %18.91 %
201663.97 %25.88 %17.59 %
201561.13 %25.3 %16.83 %
201458.61 %23.02 %15.58 %
201355.33 %20.26 %13.86 %
201253.22 %17.96 %12.41 %
201154.87 %19.3 %10.37 %
201053.92 %19.79 %14.23 %
200953.76 %22.32 %13.56 %
200850.32 %16.23 %9.86 %
200758.18 %25.13 %16.16 %
200659.93 %32.08 %21.57 %
200559.93 %37.28 %25.52 %

Fisher & Paykel Healthcare Corporation Stock Sales Revenue, EBIT, Earnings per Share

The Fisher & Paykel Healthcare Corporation earnings per share therefore indicates how much revenue Fisher & Paykel Healthcare Corporation has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Fisher & Paykel Healthcare Corporation earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Fisher & Paykel Healthcare Corporation's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Fisher & Paykel Healthcare Corporation’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Fisher & Paykel Healthcare Corporation's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Fisher & Paykel Healthcare Corporation Revenue, EBIT and net profit per share

DateFisher & Paykel Healthcare Corporation Sales per ShareFisher & Paykel Healthcare Corporation EBIT per shareFisher & Paykel Healthcare Corporation Earnings per Share
2027e4.33 NZD0 NZD0.9 NZD
2026e3.86 NZD0 NZD0.75 NZD
2025e3.44 NZD0 NZD0.62 NZD
20242.97 NZD0.6 NZD0.23 NZD
20232.72 NZD0.57 NZD0.43 NZD
20222.9 NZD0.87 NZD0.65 NZD
20213.4 NZD1.23 NZD0.9 NZD
20202.18 NZD0.66 NZD0.5 NZD
20191.85 NZD0.51 NZD0.36 NZD
20181.71 NZD0.47 NZD0.33 NZD
20171.56 NZD0.42 NZD0.29 NZD
20161.43 NZD0.37 NZD0.25 NZD
20151.18 NZD0.3 NZD0.2 NZD
20141.12 NZD0.26 NZD0.17 NZD
20130.99 NZD0.2 NZD0.14 NZD
20120.96 NZD0.17 NZD0.12 NZD
20110.94 NZD0.18 NZD0.1 NZD
20100.95 NZD0.19 NZD0.14 NZD
20090.87 NZD0.19 NZD0.12 NZD
20080.68 NZD0.11 NZD0.07 NZD
20070.68 NZD0.17 NZD0.11 NZD
20060.62 NZD0.2 NZD0.13 NZD
20050.46 NZD0.17 NZD0.12 NZD

Fisher & Paykel Healthcare Corporation business model

The Fisher & Paykel Healthcare Corporation Ltd is a New Zealand company that manufactures medical devices and equipment for use in intensive care and sleep apnea therapy. The company was founded in 1934 by Sir Woolf Fisher and Maurice Paykel in Auckland and has been listed on the Australian stock exchange since 2001. The company's business model is focused on developing and manufacturing innovative medical products that can improve the lives of patients in intensive care and sleep apnea therapy. The company specializes in producing high-quality products that are easy to use and maintain. The products are available in different price and performance ranges to meet the varying needs of patients. Fisher & Paykel Healthcare operates three business segments: Sleep Apnea, Hospital, and Homecare. The Sleep Apnea segment produces and markets CPAP (Continuous Positive Airway Pressure) devices and masks. CPAP devices are used to maintain pressure in the airways during sleep, which can help protect patients from breathing interruptions. The masks are placed on the patient's face to maintain pressure on the airways. Fisher & Paykel Healthcare also offers a wide range of other CPAP products, such as accessories and consumables. The Hospital segment specializes in the production and distribution of medical accessories for hospitals. This includes ventilators, oxygen therapy devices, and moisture and heat exchangers. These products are used in intensive care to support patients who are unable to breathe on their own or require extrapulmonary oxygenation. In the Homecare segment, Fisher & Paykel Healthcare offers medical devices and accessories for home care. This includes CPAP devices for sleep apnea therapy, as well as other devices for respiratory tract infections and aerosol therapy. The company also offers accessories for caregivers and for rehabilitation and elderly care facilities. Over the years, Fisher & Paykel Healthcare has received numerous awards for its innovative products. For example, the Eson nasal mask range was nominated for the internationally renowned Red Dot Design Award in 2012. The company is also committed to using environmentally friendly materials and manufacturing processes to minimize the environmental impact of its products. Overall, Fisher & Paykel Healthcare Corporation Ltd. has developed a business model that specializes in the development of high-quality products. In particular, the three segments of Sleep Apnea, Hospital, and Homecare allow the company to manufacture a wide range of medical devices and accessories to meet different customer requirements. This has enabled the company to achieve a leading position in the global medical technology market. Fisher & Paykel Healthcare Corporation is one of the most popular companies on Eulerpool.com.

Fisher & Paykel Healthcare Corporation SWOT Analysis

Strengths

Fisher & Paykel Healthcare Corporation Ltd has a strong brand reputation in the medical devices industry, known for high-quality and innovative products.

The company has a diversified product portfolio, offering a wide range of respiratory care and sleep apnea products, which helps in capturing different market segments.

Fisher & Paykel Healthcare has a global distribution network, allowing it to reach customers in various countries and regions around the world.

Weaknesses

One weakness of Fisher & Paykel Healthcare is its reliance on third-party suppliers for certain components and raw materials, which may lead to supply chain disruptions or quality control issues.

The company faces intense competition from other global medical device manufacturers, which poses a challenge in terms of maintaining market share and profitability.

Fisher & Paykel Healthcare's pricing strategy for its premium products may limit market penetration in price-sensitive regions.

Opportunities

The increasing global prevalence of respiratory diseases and sleep apnea presents a significant opportunity for Fisher & Paykel Healthcare to expand its customer base and increase sales.

The growing aging population in many countries creates a potential market for Fisher & Paykel Healthcare's products, as older individuals are more prone to respiratory issues and require medical equipment.

Advancements in technology and increasing focus on telehealth and remote patient monitoring open doors for Fisher & Paykel Healthcare to develop innovative solutions and tap into new markets.

Threats

Fisher & Paykel Healthcare faces the risk of stricter regulations and compliance requirements in the medical device industry, which may increase costs and impact product development timelines.

The ongoing COVID-19 pandemic has disrupted healthcare systems worldwide, leading to uncertainties in demand and potential supply chain challenges.

Competitive pressures from new entrants or existing rivals who can imitate or offer similar products and technologies may threaten Fisher & Paykel Healthcare's market position.

Fisher & Paykel Healthcare Corporation Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Fisher & Paykel Healthcare Corporation historical P/E ratio, EBIT multiple, and P/S ratio

Fisher & Paykel Healthcare Corporation shares outstanding

The number of shares was Fisher & Paykel Healthcare Corporation in 2023 — This indicates how many shares 581.631 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Fisher & Paykel Healthcare Corporation earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Fisher & Paykel Healthcare Corporation's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Fisher & Paykel Healthcare Corporation’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Fisher & Paykel Healthcare Corporation's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Fisher & Paykel Healthcare Corporation stock splits

In Fisher & Paykel Healthcare Corporation's history, there have been no stock splits.

Fisher & Paykel Healthcare Corporation dividend history and estimates

In 2023, Fisher & Paykel Healthcare Corporation paid a dividend amounting to 0.64 NZD. Dividend means that Fisher & Paykel Healthcare Corporation distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Fisher & Paykel Healthcare Corporation provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Fisher & Paykel Healthcare Corporation’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Fisher & Paykel Healthcare Corporation's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Fisher & Paykel Healthcare Corporation Dividend History

DateFisher & Paykel Healthcare Corporation Dividend
2027e0.4 NZD
2026e0.4 NZD
2025e0.39 NZD
20240.37 NZD
20230.64 NZD
20220.63 NZD
20210.34 NZD
20200.06 NZD
20190.19 NZD
20180.31 NZD
20170.14 NZD
20160.13 NZD
20150.11 NZD
20140.18 NZD
20130.02 NZD
20120.02 NZD
20110.17 NZD
20100.18 NZD
20090.18 NZD
20080.19 NZD
20070.19 NZD
20060.19 NZD
20050.17 NZD

Fisher & Paykel Healthcare Corporation dividend payout ratio

In 2023, Fisher & Paykel Healthcare Corporation had a payout ratio of 48.22%. The payout ratio indicates the percentage of the company's profits that Fisher & Paykel Healthcare Corporation distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Fisher & Paykel Healthcare Corporation represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Fisher & Paykel Healthcare Corporation could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Fisher & Paykel Healthcare Corporation's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Fisher & Paykel Healthcare Corporation Payout Ratio History

DateFisher & Paykel Healthcare Corporation Payout ratio
2027e62.66 %
2026e59.05 %
2025e68.38 %
202460.56 %
202348.22 %
202296.35 %
202137.1 %
202011.2 %
201952.63 %
201893.64 %
201748 %
201652.74 %
201553.93 %
2014104.58 %
201315.63 %
201218.24 %
2011172.22 %
2010126.53 %
2009147.62 %
2008264.39 %
2007168.25 %
2006142.37 %
2005139.3 %

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Fisher & Paykel Healthcare Corporation.

Fisher & Paykel Healthcare Corporation latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
3/31/20240.25 NZD0.27 NZD (5.74 %)2024 Q4
9/30/20230.18 NZD0.18 NZD (-0.16 %)2024 Q2
3/31/20230.24 NZD0.27 NZD (11.63 %)2023 Q4
9/30/20220.17 NZD0.17 NZD (-3.9 %)2023 Q2
3/31/20220.26 NZD0.27 NZD (1.68 %)2022 Q4
9/30/20210.3 NZD0.38 NZD (26.4 %)2022 Q2
3/31/20210.6 NZD0.52 NZD (-13.58 %)2021 Q4
9/30/20200.35 NZD0.39 NZD (10.04 %)2021 Q2
3/31/20200.27 NZD0.29 NZD (5.24 %)2020 Q4
9/30/20190.21 NZD0.21 NZD (-1.46 %)2020 Q2
1
2

Eulerpool ESG Scorecard© for the Fisher & Paykel Healthcare Corporation stock

Eulerpool World ESG Rating (EESG©)

85/ 100

🌱 Environment

81

👫 Social

99

🏛️ Governance

74

Environment

Scope 1 - Direct Emissions
2,122.85
Scope 2 - Indirect emissions from purchased energy
14,293.11
Scope 3 - Indirect emissions within the value chain
302,479.64
Total CO₂ emissions
16,415.96
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees53.99
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Fisher & Paykel Healthcare Corporation shareholders

%
Name
Stocks
Change
Date
7.23648 % Mitsubishi UFJ Financial Group Inc42,414,797-5,701,8519/20/2024
6.15214 % Pinnacle Investment Management Group Ltd36,059,20603/31/2024
6.04862 % Hyperion Asset Management Limited35,452,46603/31/2024
3.38868 % BlackRock Institutional Trust Company, N.A.19,861,90403/31/2024
3.10857 % The Vanguard Group, Inc.18,220,077101,0169/30/2024
2.38199 % Stewart Investors13,961,451-322,9309/30/2024
1.70571 % Norges Bank Investment Management (NBIM)9,997,618418,4226/30/2024
1.68643 % Bennelong Australian Equity Partners Pty. Ltd.9,884,5772,703,1536/30/2024
1.65014 % Accident Compensation Corporation9,671,894527,1933/31/2024
1.20952 % First Sentier Investors (Hong Kong) Limited7,089,328-160,1639/30/2024
1
2
3
4
5
...
10

Fisher & Paykel Healthcare Corporation Executives and Management Board

Mr. Lewis Gradon
Fisher & Paykel Healthcare Corporation Chief Executive Officer, Managing Director, Executive Director (since 2001)
Compensation 3.67 M NZD
Mr. Scott St John
Fisher & Paykel Healthcare Corporation Independent Non-Executive Chairman of the Board
Compensation 284,971 NZD
Mr. Neville Mitchell(63)
Fisher & Paykel Healthcare Corporation Non-Executive Independent Director
Compensation 212,809 NZD
Mr. Donal O'Dwyer(70)
Fisher & Paykel Healthcare Corporation Non-Executive Independent Director
Compensation 201,604 NZD
Dr. Lisa Mcintyre
Fisher & Paykel Healthcare Corporation Non-Executive Independent Director
Compensation 181,841 NZD
1
2
3
4

Most common questions regarding Fisher & Paykel Healthcare Corporation

What values and corporate philosophy does Fisher & Paykel Healthcare Corporation represent?

Fisher & Paykel Healthcare Corporation Ltd represents values of innovation, excellence, and care. As a leading healthcare solutions provider, the company prioritizes delivering superior products and improving patient outcomes. Fisher & Paykel Healthcare Corporation is committed to developing advanced respiratory care devices and technologies that offer increased comfort and efficiency. With a focus on user-centric design, the company strives to enhance the quality of life for patients worldwide. By integrating cutting-edge technology and compassionate care, Fisher & Paykel Healthcare Corporation is dedicated to positively impacting the healthcare industry, while continuously nurturing a culture of innovation and integrity.

In which countries and regions is Fisher & Paykel Healthcare Corporation primarily present?

Fisher & Paykel Healthcare Corporation Ltd is primarily present in several countries and regions worldwide. The company has a strong presence in North America, including the United States and Canada, where it has established significant operations. Additionally, Fisher & Paykel Healthcare Corporation Ltd has a substantial presence in Europe, with a focus on countries like Germany, France, and the United Kingdom. The company also operates in the Asia-Pacific region, specifically targeting countries such as Australia and New Zealand. Furthermore, Fisher & Paykel Healthcare Corporation Ltd has expanded its reach to other key markets, including Japan and parts of Latin America.

What significant milestones has the company Fisher & Paykel Healthcare Corporation achieved?

Fisher & Paykel Healthcare Corporation Ltd has achieved several significant milestones over the years. The company introduced the first heated humidifier for respiratory patients in 1989, revolutionizing patient care. In 2001, Fisher & Paykel Healthcare launched its innovative Optiflow nasal high flow therapy, providing a more comfortable and effective respiratory support system. The company also expanded its global presence, establishing a distribution center in Mexico in 2004 and acquiring Healthcare Technologies in 2018 to enhance its sleep apnea product offerings. Furthermore, Fisher & Paykel Healthcare received numerous awards and recognitions for its commitment to innovation, quality, and improving patient outcomes.

What is the history and background of the company Fisher & Paykel Healthcare Corporation?

Fisher & Paykel Healthcare Corporation Ltd is a renowned company that specializes in manufacturing medical devices and equipment. Established in 1934 in New Zealand, the company has a rich history and strong background in the healthcare industry. Fisher & Paykel Healthcare Corporation Ltd has grown to become a global leader in providing innovative solutions for respiratory care, sleep apnea treatment, and acute care. With a focus on research and development, the company has continually introduced cutting-edge technologies and products, earning a reputation for delivering high-quality and reliable medical devices. Fisher & Paykel Healthcare Corporation Ltd's dedication to improving patient care has made it a trusted and recognized name in the healthcare sector worldwide.

Who are the main competitors of Fisher & Paykel Healthcare Corporation in the market?

Fisher & Paykel Healthcare Corporation Ltd faces competition from several key players in the market. Some of its main competitors include ResMed Inc., which specializes in the development and manufacturing of medical equipment and devices for sleep apnea and other respiratory disorders, and Philips Respironics, a leading global healthcare company that offers respiratory and sleep solutions. Additionally, Medtronic plc, a multinational medical technology company, is also a notable competitor in the market. These companies strive to provide innovative healthcare solutions to patients worldwide, similar to Fisher & Paykel Healthcare Corporation Ltd.

In which industries is Fisher & Paykel Healthcare Corporation primarily active?

Fisher & Paykel Healthcare Corporation Ltd is primarily active in the healthcare industry.

What is the business model of Fisher & Paykel Healthcare Corporation?

The business model of Fisher & Paykel Healthcare Corporation Ltd is focused on designing, manufacturing, and marketing a range of medical devices and systems for use in respiratory care, acute care, and surgery. The company specializes in innovative solutions such as nasal high flow therapy, humidification systems, and sleep apnea devices. Fisher & Paykel Healthcare Corporation aims to improve patient outcomes and enhance the quality of care offered by healthcare professionals. With a strong commitment to research and development, the company consistently introduces cutting-edge technologies and strives to provide effective and efficient medical products and services. Fisher & Paykel Healthcare Corporation Ltd stands as a leading player in the global healthcare industry.

What is the P/E ratio of Fisher & Paykel Healthcare Corporation 2024?

The Fisher & Paykel Healthcare Corporation P/E ratio is 159.45.

What is the P/S ratio of Fisher & Paykel Healthcare Corporation 2024?

The Fisher & Paykel Healthcare Corporation P/S ratio is 12.13.

What is the Quality Investing of Fisher & Paykel Healthcare Corporation?

The Quality Investing for Fisher & Paykel Healthcare Corporation is 6/10.

What is the revenue of Fisher & Paykel Healthcare Corporation 2024?

The Fisher & Paykel Healthcare Corporation revenue is 1.74 B NZD.

How high is the profit of Fisher & Paykel Healthcare Corporation 2024?

The Fisher & Paykel Healthcare Corporation profit is 132.6 M NZD.

What is the business model of Fisher & Paykel Healthcare Corporation

Fisher & Paykel Healthcare Corporation Ltd is an internationally known company that manufactures medical devices for ventilation, oxygen therapy, and the clinical sleep area. The company's business model is based on offering high-quality and innovative products at a reasonable price to improve its customers' quality of life.

What is the Fisher & Paykel Healthcare Corporation dividend?

Fisher & Paykel Healthcare Corporation pays a dividend of 0.63 NZD distributed over 2 payouts per year.

How often does Fisher & Paykel Healthcare Corporation pay dividends?

Fisher & Paykel Healthcare Corporation pays out a dividend 2 times a year.

What is the Fisher & Paykel Healthcare Corporation ISIN?

The ISIN of Fisher & Paykel Healthcare Corporation is NZFAPE0001S2.

What is the Fisher & Paykel Healthcare Corporation WKN?

The WKN of Fisher & Paykel Healthcare Corporation is 881319.

What is the Fisher & Paykel Healthcare Corporation ticker?

The ticker of Fisher & Paykel Healthcare Corporation is FPH.NZ.

How much dividend does Fisher & Paykel Healthcare Corporation pay?

Over the past 12 months, Fisher & Paykel Healthcare Corporation paid a dividend of 0.37 NZD . This corresponds to a dividend yield of about 1.02 %. For the coming 12 months, Fisher & Paykel Healthcare Corporation is expected to pay a dividend of 0.39 NZD.

What is the dividend yield of Fisher & Paykel Healthcare Corporation?

The current dividend yield of Fisher & Paykel Healthcare Corporation is 1.02 %.

When does Fisher & Paykel Healthcare Corporation pay dividends?

Fisher & Paykel Healthcare Corporation pays a quarterly dividend. This is distributed in the months of January, July, January, July.

How secure is the dividend of Fisher & Paykel Healthcare Corporation?

Fisher & Paykel Healthcare Corporation paid dividends every year for the past 23 years.

What is the dividend of Fisher & Paykel Healthcare Corporation?

For the upcoming 12 months, dividends amounting to 0.39 NZD are expected. This corresponds to a dividend yield of 1.09 %.

In which sector is Fisher & Paykel Healthcare Corporation located?

Fisher & Paykel Healthcare Corporation is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fisher & Paykel Healthcare Corporation kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fisher & Paykel Healthcare Corporation from 7/10/2024 amounting to 0.368 NZD, you needed to have the stock in your portfolio before the ex-date on 6/26/2024.

When did Fisher & Paykel Healthcare Corporation pay the last dividend?

The last dividend was paid out on 7/10/2024.

What was the dividend of Fisher & Paykel Healthcare Corporation in the year 2023?

In the year 2023, Fisher & Paykel Healthcare Corporation distributed 0.642 NZD as dividends.

In which currency does Fisher & Paykel Healthcare Corporation pay out the dividend?

The dividends of Fisher & Paykel Healthcare Corporation are distributed in NZD.

All fundamentals about Fisher & Paykel Healthcare Corporation

Our stock analysis for Fisher & Paykel Healthcare Corporation Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fisher & Paykel Healthcare Corporation Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.